Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2020

Primary Completion Date

November 24, 2020

Study Completion Date

November 24, 2020

Conditions
LiposarcomaMalignant Peripheral Nerve Sheath TumorsAlveolar Soft Part SarcomaEwing SarcomaSarcoma
Interventions
DRUG

Selinexor

"Selinexor will be taken orally on Days 1, 8, 15, and 22 of each cycle at the following dose levels (DLs):~DL 1: 40 mg; DL 2: 60 mg; DL 3: 80 mg; DL 4: 100 mg~The selinexor product is provided as 20 mg tablets in wallet-sized blister packs. Selinexor should be taken together with ixazomib."

DRUG

Ixazomib

"Ixazomib will be taken orally on Days 1, 8, and 15 of each cycle at the same dose level: 4 mg.~The ixazomib product is provided in strengths of 4.0, 3.0, and 2.3 mg capsules as the active boronic acid. Ixazomib should be taken on an empty stomach (no food or drink) at least 1 hour before or at least 2 hours after food."

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors
All Listed Sponsors
collaborator

Karyopharm Therapeutics Inc

INDUSTRY

collaborator

Takeda

INDUSTRY

lead

Matthew Ingham

OTHER